The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolution Group PLS Regulatory News (FAN)

Share Price Information for Volution Group PLS (FAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 423.00
Bid: 422.50
Ask: 423.00
Change: 15.00 (3.68%)
Spread: 0.50 (0.118%)
Open: 411.00
High: 423.50
Low: 411.00
Prev. Close: 408.00
FAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

14 Dec 2022 07:00

RNS Number : 6111J
Volution Group plc
14 December 2022
 

 

 

 

 

 

Embargoed to 07:00

Wednesday 14 December 2022

 

 

 

Volution Group plc

AGM Trading Update for 4 months to 30 November 2022

 

Volution Group plc ("Volution" or "the Group" or "the Company", LSE: FAN), a leading international designer and manufacturer of energy efficient indoor air quality solutions, today announces an update on trading covering the four months to 30 November 2022.

 

Trading update

 

Group revenue for the four months to 30 November 2022 increased by 7% year-on-year at constant currency ("cc") to c.£112 million with organic growth of 5.5% (cc), delivered through a combination of both volume and price increases. All three geographic regions grew organically.

 

The UK delivered organic revenue growth of 3.8% (cc). Strong growth in residential markets and good growth in our OEM revenue stream, more than offset weaker revenues in commercial. In Continental Europe, organic revenue growth was 6.4% (cc). Both ClimaRad and ERI performed particularly strongly, demonstrating the continued attractiveness and growth of our heat recovery solutions. In Australasia, organic growth of 8.5% (cc) was driven by continued market share gains in Australia, and good growth in New Zealand.

 

Our excellent levels of customer service, focus on operational excellence, strong brands, attractive product portfolio and pricing power have all underpinned our ability to deliver on the Group's operating margin target. Given the economic environment it is pleasing that since the year end we have continued to see sales and profits track ahead of the same period last year.

 

The Group retains a strong balance sheet, with leverage at historically low levels, providing us with opportunity for potential earnings enhancing acquisitions.

 

Regulatory drivers

 

We continue to see strong regulatory initiatives driven by the need to decarbonise buildings, drive improvements in air quality, and reduce damp and mould in residential homes. 

 

In the UK, the Future Homes Hub has been running a task group to help inform a planned formal consultation on the 2025 Future Homes Standard. In addition, we have had a public consultation on the Decent Home Standard for Private Rental properties, and the Secretary of State for Housing has written to council leaders and social housing providers calling for action on housing conditions, including mould and condensation.

 

In Continental Europe, regulatory improvement from the Energy Performance of Buildings Directive continues to drive sales of energy efficient continuous ventilation systems, including heat recovery. In Australia, recent changes to the National Construction Code build on existing provisions to further decrease health risks associated with condensation in new homes. 

 

Commenting on the Outlook, Ronnie George, Chief Executive Officer said:

 

"I am immensely proud of the excellent customer service we are maintaining across all of our markets and the considerable focus from our valued colleagues in delivering 'Healthy Air, Sustainably'. Although the wider macro-economic backdrop remains uncertain, the regulatory, energy efficiency and indoor air quality drivers have never been stronger.

We are pleased with the start to the new financial year and in our ability to achieve our margin targets in the face of inflation. With our geographic and end-market diversity, our ongoing focus on operational excellence, and our cash generation, we are well positioned to continue to capitalise on the many structural growth opportunities in the months ahead."

 

-Ends-

 

 

For further information: 

Volution Group plc

 

Ronnie George, Chief Executive Officer

+44 (0) 1293 441501

Andy O'Brien, Chief Financial Officer

+44 (0) 1293 441536

 

FTI Consulting

+44 (0) 203 727 1340

Richard Mountain

Susanne Yule

 

Volution Group plc Legal Entity Identifier: 213800EPT84EQCDHO768.

 

Note to Editors:

 

Volution Group plc (LSE: FAN) is a leading international designer and manufacturer of energy efficient indoor air quality solutions. Volution Group comprises 19 key brands across three regions:

 

UK: Vent-Axia, Manrose, Diffusion, National Ventilation, Airtech, Breathing Buildings, Torin-Sifan.

Continental Europe: Fresh, PAX, VoltAir, Kair, Air Connection, Rtek, inVENTer, Ventilair, ClimaRad, ERI Corporation.

Australasia: Simx, Ventair, Manrose.

 

For more information, please go to: www.volutiongroupplc.com

 

Cautionary statement regarding forward-looking statements

This document may contain forward-looking statements which are made in good faith and are based on current expectations or beliefs, as well as assumptions about future events. You can sometimes, but not always, identify these statements by the use of a date in the future or such words as "will", "anticipate", "estimate", "expect", "project", "intend", "plan", "should", "may", "assume" and other similar words. By their nature, forward-looking statements are inherently predictive and speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. You should not place undue reliance on these forward-looking statements, which are not a guarantee of future performance and are subject to factors that could cause our actual results to differ materially from those expressed or implied by these statements. The Company undertakes no obligation to update any forward-looking statements contained in this document, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDBBDDXBBDGDX
Date   Source Headline
16th Apr 20247:00 amRNSAppointment of Joint Corporate Broker
2nd Apr 202410:00 amRNSTotal Voting Rights
2nd Apr 20249:46 amRNSHolding(s) in Company
27th Mar 20244:15 pmRNSShare Purchase by Chairman
19th Mar 20249:00 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSHalf Year Results
26th Feb 202411:30 amRNSNotice of Interim Results
10th Jan 20249:45 amRNSDirector Declaration
8th Jan 202412:00 pmRNSHolding(s) in Company
13th Dec 20232:00 pmRNSResults of AGM
13th Dec 20237:00 amRNSAGM Trading Update
11th Dec 20233:30 pmRNSAuditor Resignation
1st Dec 20232:00 pmRNSTotal Voting Rights
15th Nov 20234:45 pmRNSDirector/PDMR Shareholding
1st Nov 20234:15 pmRNSTotal Voting Rights
23rd Oct 20234:00 pmRNSDirector/PDMR Shareholding
19th Oct 20233:35 pmRNSAnnual Report 2023 & Notice of AGM
13th Oct 20234:30 pmRNSDirector/PDMR Shareholding
12th Oct 202312:20 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSPreliminary Results for year ended 31 July 2023
3rd Oct 20236:15 pmRNSTotal Voting Rights
23rd Aug 20233:53 pmRNSHolding(s) in Company
16th Aug 20235:22 pmRNSHolding(s) in Company
1st Aug 20234:00 pmRNSTotal Voting Rights
20th Jul 20237:00 amRNSPre-close Trading Update
17th Jul 202310:00 amRNSNotice of Pre-close Trading Update
3rd Jul 20235:15 pmRNSTotal Voting Rights
27th Jun 20235:00 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSCompletion of Acquisition
19th Jun 20239:00 amRNSBoard Appointment
1st Jun 20234:30 pmRNSTotal Voting Rights
31st May 20231:30 pmRNSDirector Declaration
20th Apr 20237:00 amRNSAcquisitions Announcement
3rd Apr 202312:15 pmRNSTotal Voting Rights
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20231:36 pmRNSAppointment of Chair Designate
9th Mar 20237:00 amRNSHalf year Results
8th Mar 20233:50 pmRNSDirectorate Change
1st Mar 20234:30 pmRNSTotal Voting Rights
20th Feb 20231:00 pmRNSNotice of Interim Results
1st Feb 20234:00 pmRNSTotal Voting Rights
1st Feb 20233:45 pmRNSChange of Auditor
3rd Jan 20234:30 pmRNSTotal Voting Rights
14th Dec 20224:05 pmRNSResults of AGM
14th Dec 20227:00 amRNSAGM Trading Update
13th Dec 20223:00 pmRNSHolding(s) in Company
1st Dec 20224:05 pmRNSTotal Voting Rights
1st Nov 20224:00 pmRNSTotal Voting Rights
26th Oct 20228:45 amRNSDirector Declaration
21st Oct 20223:30 pmRNSAnnual Report 2022 & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.